Healthcare provider profile · identity verified

Alan K Rogers, MD

Internal Medicine · TUCSON, AZ · NPI 1821037474

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	360	167
Rosuvastatin Calcium	Rosuvastatin Calcium	292	132
Atorvastatin Calcium	Atorvastatin Calcium	254	125
Lisinopril	Lisinopril	206	98
Amlodipine Besylate	Amlodipine Besylate	202	102
Omeprazole	Omeprazole	201	97
Losartan Potassium	Losartan Potassium	189	90
Simvastatin	Simvastatin	165	81
Tamsulosin Hcl	Tamsulosin Hcl	130	60
Allopurinol	Allopurinol	124	52
Gabapentin	Gabapentin	121	64
Metformin Hcl	Metformin Hcl	111	54
Pantoprazole Sodium	Pantoprazole Sodium	111	50
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	102	47
Metoprolol Succinate	Metoprolol Succinate	98	47
Hydrochlorothiazide	Hydrochlorothiazide	95	40
Eliquis	Apixaban	87	31
Zolpidem Tartrate	Zolpidem Tartrate	85	52
Furosemide	Furosemide	75	38
Trazodone Hcl	Trazodone Hcl	67	32
Ozempic	Semaglutide	64	16
Estradiol	Estradiol	62	25
Carvedilol	Carvedilol	61	27
Escitalopram Oxalate	Escitalopram Oxalate	61	32
Lorazepam	Lorazepam	60	36
Potassium Chloride	Potassium Chloride	60	31
Alprazolam	Alprazolam	59	36
Finasteride	Finasteride	58	25
Metoprolol Tartrate	Metoprolol Tartrate	58	25
Albuterol Sulfate Hfa	Albuterol Sulfate	56	31
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	55	39
Pravastatin Sodium	Pravastatin Sodium	53	26
Meloxicam	Meloxicam	52	25
Ezetimibe	Ezetimibe	50	22
Montelukast Sodium	Montelukast Sodium	50	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	24
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	45	24
Atenolol	Atenolol	41	21
Duloxetine Hcl	Duloxetine Hcl	41	19
Alendronate Sodium	Alendronate Sodium	40	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	38	15
Celecoxib	Celecoxib	37	18
Famotidine	Famotidine	36	18
Metformin Hcl Er	Metformin Hcl	36	19
Citalopram Hbr	Citalopram Hydrobromide	35	19
Diazepam	Diazepam	34	18
Ibuprofen	Ibuprofen	33	18
Ciprofloxacin Hcl	Ciprofloxacin Hcl	32	26
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	12
Sertraline Hcl	Sertraline Hcl	32	17
Temazepam	Temazepam	32	15
Tramadol Hcl	Tramadol Hcl	32	21
Glipizide	Glipizide	31	16
Clopidogrel	Clopidogrel Bisulfate	30	15
Bupropion Xl	Bupropion Hcl	29	12
Spironolactone	Spironolactone	29	14
Doxycycline Hyclate	Doxycycline Hyclate	28	26
Fluoxetine Hcl	Fluoxetine Hcl	28	16
Lovastatin	Lovastatin	28	15
Mounjaro	Tirzepatide	28	suppressed
Warfarin Sodium	Warfarin Sodium	28	13
Acyclovir	Acyclovir	27	11
Benazepril Hcl	Benazepril Hcl	26	13
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Fluticasone Propionate	Fluticasone Propionate	25	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Synthroid	Levothyroxine Sodium	25	14
Xarelto	Rivaroxaban	24	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	23	11
Paroxetine Hcl	Paroxetine Hcl	23	11
Irbesartan	Irbesartan	21	suppressed
Nebivolol Hcl	Nebivolol Hcl	21	suppressed
Terazosin Hcl	Terazosin Hcl	21	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	20	20
Repatha Sureclick	Evolocumab	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Clonazepam	Clonazepam	19	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Azelastine Hcl	Azelastine Hcl	18	suppressed
Azithromycin	Azithromycin	18	15
Baclofen	Baclofen	18	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	18	suppressed
Prednisone	Prednisone	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Indapamide	Indapamide	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Descovy	Emtricitabine/Tenofov Alafenam	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Prolia	Denosumab	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	11
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Digoxin	Digoxin	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error